Plain-English translation of NCT07153471 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a medication called to see if it can help people who struggle with weight and have osteoarthritis (wear-and-tear damage) in their knees. The study will compare the medication to a placebo (a dummy pill with no active ingredient) to measure how well it works and how safe it is. About 800 people will participate over roughly 18 months.
People with extra weight often have worse knee arthritis and more pain, making it harder to stay active and lose weight. This medication might help break that cycle by addressing both the weight and the joint damage at the same time.
You likely qualify if…
You likely don't qualify if…
You would take the medication (or placebo) once daily by mouth for about 74 weeks (just over a year). You would attend clinic visits to check how the treatment is working, how your knee pain is doing, and whether you are experiencing any side effects. The study team will track your weight, knee function, and overall health throughout the trial.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States